Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders
Nutrients · 15.04.2025 · 17 (8) · 1353
DOI: 10.3390/nu17081353 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 15.04.2025. Verfasst von Jed W Fahey und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. Hauptthemen laut MEDLINE: Isothiocyanates, Brain, Neuroprotective Agents. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 278 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The brain accounts for about 2% of the body’s weight, but it consumes about 20% of the body’s energy at rest, primarily derived from ATP produced in mitochondria. The brain thus has a high mitochondrial density in its neurons because of its extensive energy demands for maintaining ion gradients, neurotransmission, and synaptic activity. The brain is also extremely susceptible to damage and dysregulation caused by inflammation (neuroinflammation) and oxidative stress. Many systemic challenges to the brain can be mitigated by the phytochemical sulforaphane (SF), which is particularly important in supporting mitochondrial function. SF or its biogenic precursor glucoraphanin, from broccoli seeds or sprouts, can confer neuroprotective and cognitive benefits via diverse physiological and biochemical mechanisms. SF is able to cross the blood–brain barrier as well as to protect it, and it mitigates the consequences of destructive neuroinflammation. It also protects against the neurotoxic effects of environmental pollutants, combats the tissue and cell damage wrought by advanced glycation end products (detoxication), and supports healthy glucose metabolism. These effects are applicable to individuals of all ages, from the developing brains in periconception and infancy, to cognitively, developmentally, and traumatically challenged brains, to those in later life as well as those who are suffering with multiple chronic conditions including Parkinson’s and Alzheimer’s diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Department of Pharmacology and Molecular Sciences, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- iMIND Institute, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
- Institute of Medicine, University of Maine, Orono, ME 04469, USA.
- Stanley Division of Developmental Neurovirology, Department of Pediatrics, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.
ORCID-Profile: Jed W Fahey, Hua Liu, Holly Batt, Anita A Panjwani, Petra Tsuji
Zitieren
APA
Fahey, J. W., Liu, H., Batt, H., Panjwani, A. A., & Tsuji, P. (2025). Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders. Nutrients, 17(8), 1353. https://doi.org/10.3390/nu17081353
Vancouver
Fahey JW, Liu H, Batt H, Panjwani AA, Tsuji P. Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders. Nutrients. 2025;17(8):1353. doi:10.3390/nu17081353
BibTeX
@article{Fahey2025,
author = {Fahey, Jed W and Liu, Hua and Batt, Holly and Panjwani, Anita A and Tsuji, Petra},
title = {Sulforaphane and Brain Health: From Pathways of Action to Effects on Specific Disorders},
journal = {Nutrients},
year = {2025},
volume = {17},
number = {8},
pages = {1353},
doi = {10.3390/nu17081353}
}
EUVIMED